Skip to main content
$3.97 -$0.01 (-0.3%)

04:00 PM EST on 02/06/23

Palatin Technologies Inc (NYSEMKT:PTN)

CAPS Rating: No stars

A biopharmaceutical company, which focuses on discovering and developing targeted, receptor-specific small molecule and peptide therapeutics, including melanocortin-based therapeutics.

Current Price $3.97 Mkt Cap $41.1M
Open $4.09 P/E Ratio 0.00
Prev. Close $3.97 Div. (Yield) $0.00 (0.0%)
Daily Range $3.80 - $4.09 Volume 20
52-Wk Range $2.14 - $13.00 Avg. Daily Vol. 87,271

Caps

How do you think NYSEMKT:PTN will perform against the market?

Add Stock to CAPS Watchlist

All Players

125 Outperform
5 Underperform
 

All-Star Players

17 Outperform
2 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NYSEMKT:PTN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

LPTIM (< 20)
Submitted February 15, 2021

MOVING UP FOR SURE TAKE A LOOK

allstar31 (99.94)
Submitted September 13, 2014

An injectable ED Drug? Yeah I don't think that's going to work.http://www.thestreet.com/story/11171001/2/biotech-stock-mailbag-ranking-cheap-biotechs.html

Fools bullish on NYSEMKT:PTN are also bullish on:

Fools bearish on NYSEMKT:PTN are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about PTN.

Recs

1
Member Avatar LPTIM (< 20) Submitted: 2/14/2021 8:06:16 PM : Outperform Start Price: $4.61 NYSE MKT:PTN Score: -16.37

MOVING UP FOR SURE
TAKE A LOOK

Recs

1
Member Avatar sk2129 (34.60) Submitted: 9/17/2015 11:04:53 AM : Outperform Start Price: $28.00 NYSE MKT:PTN Score: -179.31

baker bros

Recs

1
Member Avatar vzuopsref (< 20) Submitted: 8/16/2015 8:52:10 AM : Outperform Start Price: $27.00 NYSE MKT:PTN Score: -181.67

Pending FDA approval of competitor's similar drug

Leaderboard

Find the members with the highest scoring picks in PTN.

Score Leader

007191

007191 (< 20) Score: +311.25

The Score Leader is the player with the highest score across all their picks in PTN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
007191 < 20 10/18/2006 Underperform 1Y $68.50 -94.20% +217.05% +311.25 0 Comment
Perse1 < 20 2/12/2007 Underperform 1Y $56.25 -92.94% +202.23% +295.17 0 Comment
jbwest 87.21 3/22/2007 3/26/2008 Underperform 1Y $47.00 -91.55% +202.00% +293.56 0 Comment
allstar31 99.94 9/15/2014 Underperform 5Y $23.75 -83.28% +105.79% +189.08 1 Comment
bbbensphone 76.33 2/29/2016 Underperform 5Y $12.50 -68.24% +110.07% +178.31 0 Comment
Almostperfect1 73.44 12/23/2022 Outperform 5Y $2.36 +68.22% +7.92% +60.30 0 Comment
mn1 < 20 8/31/2022 Outperform 5Y $4.61 -13.88% +2.48% -16.37 0 Comment
kfassini < 20 8/31/2022 Outperform 5Y $4.61 -13.88% +2.48% -16.37 0 Comment
LPTIM < 20 8/31/2022 Outperform 3M $4.61 -13.88% +2.48% -16.37 1 Comment
squidulin < 20 8/31/2022 Outperform 5Y $4.61 -13.88% +2.48% -16.37 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for PTN.